Melissa Susan Putman, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Cystic Fibrosis | 23 | 2024 | 1177 | 7.700 |
Why?
|
Bone Density | 14 | 2021 | 3468 | 1.700 |
Why?
|
Radius | 7 | 2021 | 422 | 1.490 |
Why?
|
Diabetes Mellitus | 8 | 2024 | 5751 | 1.470 |
Why?
|
Insulin Infusion Systems | 5 | 2024 | 212 | 1.440 |
Why?
|
Glucose Intolerance | 2 | 2023 | 577 | 1.330 |
Why?
|
Tibia | 7 | 2016 | 1077 | 1.220 |
Why?
|
Blood Glucose Self-Monitoring | 7 | 2024 | 434 | 1.080 |
Why?
|
Hyperglycemia | 3 | 2024 | 1373 | 1.060 |
Why?
|
Hypoglycemia | 2 | 2024 | 861 | 1.040 |
Why?
|
Blood Glucose | 11 | 2024 | 6256 | 1.030 |
Why?
|
Human Growth Hormone | 2 | 2021 | 683 | 1.000 |
Why?
|
Aminophenols | 3 | 2022 | 78 | 1.000 |
Why?
|
Diabetes Mellitus, Type 1 | 4 | 2024 | 3336 | 0.980 |
Why?
|
Quinolones | 3 | 2022 | 367 | 0.930 |
Why?
|
Pancreas, Artificial | 2 | 2020 | 54 | 0.890 |
Why?
|
Bone Diseases | 3 | 2019 | 416 | 0.800 |
Why?
|
Absorptiometry, Photon | 8 | 2022 | 1725 | 0.780 |
Why?
|
Insulin | 6 | 2024 | 6580 | 0.760 |
Why?
|
Cystic Fibrosis Transmembrane Conductance Regulator | 5 | 2023 | 437 | 0.720 |
Why?
|
Fractures, Bone | 3 | 2018 | 1947 | 0.700 |
Why?
|
Hypoglycemic Agents | 5 | 2024 | 2872 | 0.670 |
Why?
|
Gastrointestinal Agents | 2 | 2020 | 494 | 0.660 |
Why?
|
Bone and Bones | 4 | 2021 | 2575 | 0.650 |
Why?
|
Glucagon | 1 | 2019 | 533 | 0.590 |
Why?
|
Monitoring, Ambulatory | 1 | 2020 | 355 | 0.590 |
Why?
|
Growth Disorders | 2 | 2019 | 645 | 0.580 |
Why?
|
Body Composition | 3 | 2022 | 2401 | 0.500 |
Why?
|
Eating | 1 | 2022 | 1536 | 0.500 |
Why?
|
Bionics | 3 | 2024 | 42 | 0.470 |
Why?
|
Tibial Fractures | 1 | 2017 | 269 | 0.470 |
Why?
|
Fibrous Dysplasia of Bone | 1 | 2013 | 54 | 0.440 |
Why?
|
Body Height | 1 | 2018 | 1577 | 0.420 |
Why?
|
Forearm | 1 | 2013 | 409 | 0.370 |
Why?
|
Adipose Tissue | 1 | 2022 | 3279 | 0.350 |
Why?
|
Lung Transplantation | 1 | 2018 | 1153 | 0.340 |
Why?
|
Technology | 2 | 2022 | 305 | 0.340 |
Why?
|
Adolescent | 15 | 2023 | 85781 | 0.300 |
Why?
|
Adult | 20 | 2024 | 214055 | 0.280 |
Why?
|
Exercise | 1 | 2022 | 5615 | 0.260 |
Why?
|
Research | 2 | 2023 | 1999 | 0.240 |
Why?
|
Young Adult | 11 | 2022 | 56430 | 0.240 |
Why?
|
Vitamin D | 2 | 2019 | 3223 | 0.230 |
Why?
|
Telemedicine | 1 | 2020 | 2872 | 0.220 |
Why?
|
Humans | 43 | 2024 | 744343 | 0.220 |
Why?
|
Vitamin D Deficiency | 1 | 2012 | 1343 | 0.220 |
Why?
|
Diabetes Mellitus, Type 2 | 3 | 2022 | 11725 | 0.210 |
Why?
|
Benzodioxoles | 1 | 2021 | 69 | 0.200 |
Why?
|
Case-Control Studies | 6 | 2022 | 21746 | 0.180 |
Why?
|
Quality of Life | 4 | 2022 | 12804 | 0.170 |
Why?
|
Pyrrolidines | 1 | 2021 | 342 | 0.170 |
Why?
|
Growth Hormone | 1 | 2021 | 705 | 0.160 |
Why?
|
Child | 8 | 2022 | 77709 | 0.160 |
Why?
|
Bone Diseases, Metabolic | 2 | 2019 | 417 | 0.160 |
Why?
|
Diet Surveys | 1 | 2022 | 1173 | 0.150 |
Why?
|
Pancreas | 1 | 2024 | 1686 | 0.140 |
Why?
|
Male | 18 | 2023 | 350118 | 0.140 |
Why?
|
Amino Acid Substitution | 1 | 2021 | 1791 | 0.140 |
Why?
|
Vital Capacity | 1 | 2018 | 925 | 0.140 |
Why?
|
Female | 25 | 2022 | 380194 | 0.130 |
Why?
|
Immobilization | 1 | 2016 | 236 | 0.130 |
Why?
|
Fasting | 2 | 2018 | 1593 | 0.130 |
Why?
|
Exercise Tolerance | 1 | 2018 | 770 | 0.120 |
Why?
|
Forced Expiratory Volume | 1 | 2018 | 1743 | 0.120 |
Why?
|
Hypogonadism | 1 | 2019 | 799 | 0.110 |
Why?
|
Diphosphonates | 1 | 2018 | 623 | 0.110 |
Why?
|
Indoles | 1 | 2021 | 1839 | 0.110 |
Why?
|
Infertility | 1 | 2019 | 655 | 0.110 |
Why?
|
Postmenopause | 1 | 2021 | 2461 | 0.110 |
Why?
|
Body Mass Index | 2 | 2022 | 12720 | 0.110 |
Why?
|
Cross-Sectional Studies | 3 | 2022 | 25043 | 0.100 |
Why?
|
Nutrition Disorders | 3 | 2000 | 211 | 0.100 |
Why?
|
Mutation, Missense | 1 | 2021 | 2564 | 0.100 |
Why?
|
Finite Element Analysis | 1 | 2013 | 431 | 0.100 |
Why?
|
Weight-Bearing | 1 | 2013 | 515 | 0.100 |
Why?
|
Pyrazoles | 1 | 2021 | 1972 | 0.100 |
Why?
|
Menstruation | 1 | 2012 | 302 | 0.090 |
Why?
|
Forecasting | 1 | 2019 | 2951 | 0.090 |
Why?
|
Hospitals, Pediatric | 1 | 2019 | 1775 | 0.090 |
Why?
|
Cohort Studies | 3 | 2021 | 40561 | 0.090 |
Why?
|
Models, Animal | 1 | 2016 | 2171 | 0.090 |
Why?
|
Drug Prescriptions | 1 | 2019 | 1637 | 0.090 |
Why?
|
Pyridines | 1 | 2021 | 2825 | 0.090 |
Why?
|
Cost of Illness | 1 | 2019 | 1859 | 0.090 |
Why?
|
Anticonvulsants | 1 | 2019 | 1916 | 0.090 |
Why?
|
Tomography, X-Ray Computed | 5 | 2016 | 20129 | 0.090 |
Why?
|
Recombinant Proteins | 1 | 2018 | 6622 | 0.080 |
Why?
|
Amenorrhea | 1 | 2012 | 485 | 0.080 |
Why?
|
Body Weight | 1 | 2018 | 4669 | 0.080 |
Why?
|
Child, Preschool | 3 | 2021 | 41006 | 0.080 |
Why?
|
Intensive Care Units | 1 | 2020 | 3679 | 0.070 |
Why?
|
Middle Aged | 9 | 2022 | 213383 | 0.070 |
Why?
|
Patient Satisfaction | 1 | 2019 | 3396 | 0.070 |
Why?
|
Gastric Bypass | 1 | 2015 | 812 | 0.070 |
Why?
|
Osteoporosis | 1 | 2015 | 1580 | 0.070 |
Why?
|
Sports | 1 | 2012 | 688 | 0.070 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2019 | 9959 | 0.060 |
Why?
|
History, 20th Century | 1 | 2013 | 2740 | 0.060 |
Why?
|
Equipment Design | 1 | 2013 | 3582 | 0.060 |
Why?
|
Quality Improvement | 1 | 2019 | 3749 | 0.060 |
Why?
|
Obesity, Morbid | 1 | 2015 | 1213 | 0.060 |
Why?
|
beta-Galactosidase | 2 | 1997 | 573 | 0.060 |
Why?
|
Epilepsy | 1 | 2019 | 3310 | 0.060 |
Why?
|
Infant | 4 | 2024 | 35136 | 0.060 |
Why?
|
Retrospective Studies | 3 | 2022 | 77449 | 0.060 |
Why?
|
Lung | 1 | 2022 | 9856 | 0.060 |
Why?
|
alpha-Glucosidases | 2 | 2000 | 44 | 0.050 |
Why?
|
Prospective Studies | 2 | 2024 | 53288 | 0.050 |
Why?
|
Periodicals as Topic | 1 | 2013 | 1432 | 0.050 |
Why?
|
Medication Adherence | 1 | 2012 | 2063 | 0.050 |
Why?
|
Follow-Up Studies | 3 | 2019 | 39050 | 0.050 |
Why?
|
Isoenzymes | 2 | 1998 | 1726 | 0.050 |
Why?
|
Muscle, Skeletal | 1 | 2016 | 4931 | 0.050 |
Why?
|
Prevalence | 1 | 2018 | 15226 | 0.050 |
Why?
|
Endometriosis | 2 | 1999 | 839 | 0.050 |
Why?
|
Dietary Supplements | 1 | 2012 | 3297 | 0.040 |
Why?
|
Boston | 1 | 2012 | 9313 | 0.040 |
Why?
|
Lactation | 1 | 2022 | 412 | 0.040 |
Why?
|
17-Hydroxysteroid Dehydrogenases | 1 | 1998 | 55 | 0.040 |
Why?
|
Double-Blind Method | 1 | 2012 | 12026 | 0.040 |
Why?
|
Obesity | 1 | 2020 | 12745 | 0.040 |
Why?
|
Age Factors | 1 | 2015 | 18370 | 0.040 |
Why?
|
Multicenter Studies as Topic | 1 | 2022 | 1677 | 0.040 |
Why?
|
Lumbar Vertebrae | 2 | 2015 | 1848 | 0.030 |
Why?
|
Aromatase Inhibitors | 1 | 1999 | 491 | 0.030 |
Why?
|
United States | 2 | 2021 | 69872 | 0.030 |
Why?
|
Infant, Newborn | 2 | 2013 | 25625 | 0.030 |
Why?
|
Porosity | 1 | 2014 | 362 | 0.030 |
Why?
|
Risk Factors | 2 | 2020 | 72290 | 0.030 |
Why?
|
Jejunum | 2 | 1992 | 480 | 0.030 |
Why?
|
Hip | 1 | 2015 | 257 | 0.030 |
Why?
|
Time Factors | 1 | 2015 | 40075 | 0.030 |
Why?
|
Risk Assessment | 1 | 2014 | 23338 | 0.030 |
Why?
|
Enzyme Precursors | 1 | 1992 | 176 | 0.030 |
Why?
|
Aged | 2 | 2022 | 163280 | 0.030 |
Why?
|
Estrogens | 1 | 1999 | 1566 | 0.030 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 1997 | 1213 | 0.030 |
Why?
|
Diarrhea, Infantile | 1 | 1992 | 109 | 0.030 |
Why?
|
Microvilli | 1 | 1992 | 241 | 0.030 |
Why?
|
Health Care Surveys | 1 | 2019 | 2453 | 0.030 |
Why?
|
Respiratory Function Tests | 1 | 2015 | 1616 | 0.020 |
Why?
|
Estradiol | 1 | 1998 | 2020 | 0.020 |
Why?
|
Intestines | 1 | 2000 | 1924 | 0.020 |
Why?
|
Rabbits | 1 | 2016 | 4894 | 0.020 |
Why?
|
Respiration, Artificial | 1 | 2020 | 2569 | 0.020 |
Why?
|
Intestinal Mucosa | 3 | 2000 | 3036 | 0.020 |
Why?
|
Enzyme Inhibitors | 1 | 1999 | 3798 | 0.020 |
Why?
|
Odds Ratio | 1 | 2020 | 9849 | 0.020 |
Why?
|
Hip Joint | 1 | 2014 | 1002 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2022 | 7913 | 0.020 |
Why?
|
Treatment Outcome | 1 | 2012 | 63114 | 0.020 |
Why?
|
Comorbidity | 1 | 2020 | 10388 | 0.020 |
Why?
|
Adiposity | 1 | 2015 | 1807 | 0.020 |
Why?
|
Logistic Models | 1 | 2020 | 13408 | 0.020 |
Why?
|
Sucrase | 2 | 1997 | 54 | 0.020 |
Why?
|
Lactase | 2 | 1997 | 69 | 0.020 |
Why?
|
Phenotype | 1 | 2022 | 16365 | 0.020 |
Why?
|
Weight Loss | 1 | 2015 | 2622 | 0.010 |
Why?
|
Insulin Resistance | 1 | 2014 | 3864 | 0.010 |
Why?
|
Pregnancy | 1 | 2022 | 29144 | 0.010 |
Why?
|
Sodium-Glucose Transporter 1 | 1 | 2000 | 112 | 0.010 |
Why?
|
Receptors, Estradiol | 1 | 1998 | 19 | 0.010 |
Why?
|
RNA, Messenger | 3 | 2000 | 13033 | 0.010 |
Why?
|
Disease Progression | 1 | 2015 | 13284 | 0.010 |
Why?
|
Aromatase | 1 | 1999 | 146 | 0.010 |
Why?
|
Prognosis | 1 | 2019 | 29063 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2012 | 12245 | 0.010 |
Why?
|
Monosaccharide Transport Proteins | 1 | 2000 | 440 | 0.010 |
Why?
|
Blotting, Northern | 1 | 1998 | 1581 | 0.010 |
Why?
|
Endometrium | 1 | 1998 | 424 | 0.010 |
Why?
|
Atrophy | 1 | 2000 | 1583 | 0.010 |
Why?
|
Microfilament Proteins | 1 | 2000 | 1152 | 0.010 |
Why?
|
Receptors, Progesterone | 1 | 1998 | 1097 | 0.010 |
Why?
|
Aging | 1 | 1992 | 8664 | 0.010 |
Why?
|
Oligo-1,6-Glucosidase | 1 | 1992 | 7 | 0.010 |
Why?
|
Actins | 1 | 2000 | 2121 | 0.010 |
Why?
|
Aminopeptidases | 1 | 1992 | 88 | 0.010 |
Why?
|
Nutritional Status | 1 | 2000 | 1609 | 0.010 |
Why?
|
Reference Values | 1 | 1998 | 4982 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 1998 | 4751 | 0.010 |
Why?
|
Membrane Glycoproteins | 1 | 2000 | 3768 | 0.010 |
Why?
|
Thyroxine | 1 | 1992 | 667 | 0.010 |
Why?
|
Fluorescent Antibody Technique | 1 | 1992 | 2505 | 0.000 |
Why?
|
Biopsy | 1 | 2000 | 6756 | 0.000 |
Why?
|
Animals | 2 | 2016 | 168757 | 0.000 |
Why?
|
Carrier Proteins | 1 | 2000 | 5021 | 0.000 |
Why?
|
Immunohistochemistry | 1 | 1998 | 11366 | 0.000 |
Why?
|
Microscopy, Fluorescence | 1 | 1992 | 2699 | 0.000 |
Why?
|
Genotype | 1 | 1997 | 12951 | 0.000 |
Why?
|
Chronic Disease | 1 | 1992 | 9146 | 0.000 |
Why?
|
Rats | 1 | 1992 | 24260 | 0.000 |
Why?
|